Hepatitis C Management in Special Populations

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 8/17/18 (What's New)


  • HCV transmission is most efficient through percutaneous exposure to contaminated blood, which is often present in needles and drug preparation materials shared among PWID[Zibbell 2015; Doerrbecker 2013]
  • The WHO estimates that 5.6 million (8%) of the 71 million individuals with chronic HCV infection worldwide are currently engaged with IDU, whereas a greater yet undefined proportion were formerly engaged with IDU[WHO 2017]
  • HCV prevalence is greater among PWID, with seroprevalence rates of 10% to 70% among PWID in the US and Europe[AASLD-IDSA HCV]

    Action required